Mr. Steven Herlich is a pharmacist who is specialized in Nuclear in Beltsville, Maryland. Patients can reach him at 12300 Kiln Court, Suite D, Beltsville or contact him on 301-210-4343. Active license number of Mr. Steven Herlich is 09808 for Nuclear in Maryland. Mr. Steven Herlich is a licensed pharmacist who has demonstrated specialized knowledge and skill in procurement, compounding, quality control testing, dispensing, distribution, and monitoring of radiopharmaceuticals.
Complete Profile:
Mr. Steven Herlich speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Mr. Steven Herlich
Specialization:
Nuclear
Credentials:
R.PH.
Gender:
Male
Location:
12300 Kiln Court, Suite D, Beltsville, Maryland, 21136
Phone:
301-210-4343
Fax:
301-210-6996
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Mr. Steven Herlich are as mentioned below.
NPI Number:
1548481443
NPI Enumeration Date:
01 May, 2007
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Mr. Steven Herlich are as mentioned below.
Specialization
License Number
State
Status
Nuclear
09808
Maryland
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
805 Champions Court, Reisterstown, Maryland
Zip:
21136
Phone Number:
410-526-7446
Fax Number:
--
Patients can reach Mr. Steven Herlich at 12300 Kiln Court, Suite D, Beltsville, Maryland or can call on phone at 301-210-4343.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.